expert discusses practice-changing data from katherine trial in breast cancer
Published 5 years ago • 152 plays • Length 1:18Download video MP4
Download video MP3
Similar videos
-
1:56
dr. rimawi discusses katherine trial in her2 breast cancer
-
6:04
katherine trial updates for her2-positive breast cancer
-
6:53
treating early her2 breast cancer: katherine
-
1:18
dr. hamilton discusses the katherine trial in her2 breast cancer
-
14:35
sabcs 2023 her2 breast cancer highlights – aphinity sub-analysis, katherine update, her2climb-02
-
7:30
#esmo21 expert video report on her2-positive metastatic breast cancer
-
4:52
3-year dfs in randomized trials of chemotherapy and her2-targeted therapy
-
47:29
optimizing therapy in her2 disease with dr. reshma mahtani
-
6:40
her2 breast cancer: managing patients on t-dm1
-
4:39
case 1: approach to early stage, her2 breast cancer
-
30:57
treatment updated for her2 positive breast cancer: changing paradigms
-
1:21
katherine trial tests trastuzumab emtansine in breast cancer recurrence
-
5:15
case review: t-dm1 for residual her2 breast cancer
-
52:21
new & supporting data for optimizing therapy in her2 breast cancer | dr. irene and dr. vogel
-
1:31
dr. geyer on the rationale for the katherine trial in her2-positive breast cancer
-
6:01
treating low-risk her2-positive breast cancer
-
3:30
the aphinity trial in early-stage her2 breast cancer
-
34:21
expanding options for her2 advanced breast cancer: taking trial data to the clinic
-
6:35
treatment for high- and low-risk her2 breast cancer